Skip to content

Clinical trials

Phase 2 Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: Japan Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20082
20101
20111
20124
20133
20143
20151
20161
20171
20184
20191
20201
20223
20232
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting12
Recruiting7
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie10
Novartis Pharmaceuticals6
Pfizer4
AstraZeneca3
Eli Lilly and Company3
Amgen1
Astellas Pharma Global Development, Inc.1
Bayer1
Bristol-Myers Squibb1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms41
Carcinoma, Non-Small-Cell Lung7
Breast Neoplasms6
Colorectal Neoplasms4
Neoplasm Metastasis4
Biliary Tract Neoplasms3
Multiple Myeloma3
Brain Neoplasms2
Gastrointestinal Stromal Tumors2
Glioma2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.